Biopharmaceutical industry of China developed behind the leading countries, however, it is growing dramatically fast during past decades. Chinese government invested in biopharmaceuticals, as well as made the supporting policies. At present, biopharmaceutical industry is one of the leading industries in China.
There were 36 listed biopharmaceutical companies in 2015, the volume of sales reached RMB50.59 billion, and the net profit obtained RMB9.24 billion.
Keep pace with the development of latest biopharmaceutical technologies, this industry dominated the whole pharmaceutical industry. Meanwhile, the awareness of health life style of people has changed a lot, which focuses much more on preventions instead of therapy treatments. Those factors become incentives to the progress of biopharmaceutical enterprises.
1)The Aim of this report
-To provide readers with comprehensive & in-depth understanding of China’s bio-pharmaceutical industry;
-To understand the development situation of bio-pharmaceutical industry in China;
-Get more information of the major bio-pharmaceutical producers in China;
-Gain insight into the major bio-pharmaceutical producers about operation;
-To predict what future of China bio-pharmaceutical industry will be;
-To reveal opportunities in China bio-pharmaceutical industry.
2)Benefit from the report
-Financial performance in 2015 and YoY changes, including revenue, operating profit, net profit, revenue and gross profit margin from bio-pharmaceutical business;
-Changes of revenue and net profit in the latest five years and the reasons;
-Adjustment to business structure in the recent 2-3 years;
-Development strategy and development trends in the near future.
PDF-format report, with around 30-50 pages.
Three working days needed.
ENQUIRE FOR DISCOUNT @ New Market Study Published: Market Performance of Chinese Listed Bio-pharmaceutical Companie
1 Executive summary
2 Ranking of main listed domestic bio-pharmaceutical enterprises in 2015
2.1 List of China’s listed bio-pharmaceutical enterprises
2.2 By revenue
2.3 By net profit
2.4 By total assets
2.5 By revenue and gross profit margin of bio-pharmaceutical business
2.6 By operating profit
2.7 By primary earnings per share
3 Analysis of listed bio-pharmaceutical enterprises
3.1 Jiangsu Sihuan Bioengineering Co., LTD
3.2 Hualan Biological Engineering, Inc.
3.3 Guilin Layn Natural Ingredients Corp.
3.4 Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
3.5 Jiangxi Boya Bio-pharmaceutical Co., Ltd.
3.6 Beijing Strong Biotechnologies, Inc.
3.7 Beijing Tiantan Biological Products Corporation Limited
3.8 China Animal Husbandry Industry Co., Ltd.
3.9 Shanghai Jiaoda Onlly Co.,Ltd.
3.10 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
3.11 Shanghai RAAS Blood Products Co., Ltd.
3.12 Beijing SL Pharmaceutical Co., Ltd.
3.13 Changchun High and New Technology Industry (Group) Inc.
3.14 Shenzhen Neptunus Bioengineering Co., Ltd.
3.15 Tonghua Dongbao Pharmaceutical Co., Ltd.
3.16 Changsheng Bio-technology Co., Ltd.
3.17 Sichuan Maccura Biotechnology Co., Ltd.
3.18 Zhongyuan Union Cell & Gene Engineering Grop., Ltd.
3.19 Shanghai Kehua Bioengineering Co., Ltd.
3.20 Staidson (Beijing) Biopharmaceuticals Co., Lt
3.21 Chongqing Zhifei Biological Products Co., Ltd.
3.22 Beijing Leadman Biochemistry Co., Ltd.
3.23 Ningbo Medicalsystem Biotechnology Co., Ltd.
3.24 Anhui Anke Biotechnology (Group) Co., Ltd.
3.25 Guangzhou Wondfo Biotech Co., Ltd.
3.26 Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
3.27 Da An Gene Co., Ltd. of Sun Yat-sen University
3.28 Fujian Cosunter Pharmaceutical Co., Ltd.
3.29 Guangdong Vtr Bio-Tech Co., Ltd.
3.30 Zhong Zhu Holding Co., Ltd.
3.31 Zhenxing Biopharmaceutical and Chemical Co., Ltd.
3.32 Zhejiang Qianjiang Biochemical Co., Limited
3.33 Ginwa Enterprise (Group) Inc.
3.34 Shenzhen Cau Technology Co., Ltd.
3.35 Baotou Dongbao Bio-tech Co., Ltd.
3.36 Walvax Biotechnology Co., Ltd.
KNOW MORE WITH SAMPLE REPORT @ New Market Study Published: Market Performance of Chinese Listed Bio-pharmaceutical Companie
+1 646 845 9349 / +44 208 133 9349
P: +44 208 133 9349
M: +1 646 845 9349